Danaher logged a 0.2% change during today's afternoon session, and is now trading at a price of $265.59 per share. On average, analysts give it a target price of $281.88.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The large-cap company is based in the United States. Danaher currently returns an annual dividend yield of 0.4%.
What to Consider if You Are Thinking of Buying Danaher:
-
Danaher has moved -1.0% over the last year.
-
DHR has a forward P/E ratio of 27.3 based on its EPS guidance of 9.72.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 15.8%.
-
The company has a price to earnings growth (PEG) ratio of -997.0.
-
Its Price to Book (P/B) ratio is 3.79
Danaher Has a Pattern of Improving Cash Flows
Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
---|---|---|---|---|
2023-02-22 | 8,519,000 | -1,143,000 | 9,662,000 | 0.51 |
2022-02-23 | 8,358,000 | -1,255,000 | 9,613,000 | 55.78 |
2021-02-25 | 6,208,000 | 37,000 | 6,171,000 | 34.89 |
2020-02-21 | 3,952,000 | -623,000 | 4,575,000 | -0.54 |
2019-02-21 | 4,022,000 | -578,000 | 4,600,000 | 13.17 |
2018-02-21 | 3,477,800 | -587,000 | 4,064,800 |
Danaher's free cash flow history is impressive because it displays year-on-year increases over the last 6 years. Averaging out at $6.45 Billion, and following a compounded average growth rate of 0.0%, investors who focus on cash flow growth should do further research on this firm.